按首字母搜索

Cas号索引 2

• 2072057-17-9 | RG7834 (Catalog# : 19355)RG7834,也称为RO7020322,是一种新型口服HBV病毒基因表达抑制剂阻断病
• 252889-88-6 | RWJ-56110 (Catalog# : 19353)RWJ-56110是一种选择性蛋白酶活化受体-1 (PAR1)拮抗剂。它阻断凝血酶
• 259188-38-0 | Rebimastat (Catalog# : 192254)Rebimastat，又名BMS275291，是一种具有潜在抗肿瘤活性的巯基第二代
• 2172651-73-7 | RMC-4550 (Catalog# : 186251)RMC-4550一种有效且具有选择性的SHP2抑制剂。
• 2133832-83-2 | R-IMPP (Catalog# : 18413)R-IMPP是PCSK9的转化抑制剂。
• 2003234-63-5 | R-GNE-140 (Catalog# : 18432)R-GNE-140是一种新型高效的乳酸脱氢酶(LDHA)抑制剂，LDHA的IC50为3nM,
• 2097334-19-3 | (2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate (Catalog# : 183217)(2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopr
• 2097334-18-2 | (R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate (Catalog# : 183216)(R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate是一
• 269730-03-2 | RPI-1 (Catalog# : 17030301)RPI-1是一种ATP依赖的RET激酶抑制剂。通过口服RPI-1，导致生长阻滞
• 283173-50-2 | Rucaparib (Catalog# : 123005)Rucaparib is an inhibitor of PARP with Ki of 1.4 nM for PARP1, also showing binding a
• 27298-99-3 | (1R)-1-(4-chlorophenyl)ethanamine (Catalog# : 91124)Coming soon!
• 239105-47-6 | (1R)-1-(4-methylphenyl)propan-1-amine,hydrochloride (Catalog# : 91106)Coming soon!
• 23844-66-8 | (1R)-2-methyl-1-phenylpropan-1-amine (Catalog# : 91103)Coming soon!
• 278788-60-6 | (2R)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid (Catalog# : 81724)Coming soon!
• 213261-59-7 | RITA (Catalog# : 52526)RITA(NSC 652287) induced both DNA-protein and DNA-DNA cross-links with no detectable
• 2260969-36-4 | Selnoflast (别名:RO-7486967 ; IZD334) (Catalog# : 25167)Selnoflast，也称为 RO-7486967 或 IZD334，是一种抑制 NLRP3 炎症小体的强
• 2521285-05-0 | Sevabertinib ( 别名：BAY-2927088 ) (Catalog# : 25079)Sevabertinib ( BAY-2927088 )是一种口服非共价酪氨酸激酶受体抑制剂（
• 2805997-46-8 | Survodutide (Catalog# : 25043)
• 2097938-74-2 | Stafib-2 (Catalog# : 24142)Stafib-2 is a potent and selctive inhibitor of the transcription factor STAT5b, with
• 2589531-76-8 | Saruparib (Catalog# : 24100)Saruparib, also known as AZD5305 is a potent, selective and oral active PARP inhibito
• 2274723-90-7 | SPG-302 (Catalog# : 24065)Phenylbenzothiazole-PEG4-OH (compound 1) can treat spinal cord injury and promote spi
• 2226636-04-8 | Soquelitinib ( CPI-818 ) (Catalog# : 20671)Soquelitinib（CPI-818）是一种高度选择性的共价白细胞介素-2诱导的T
• 2222138-31-8 (HCl) | Sotuletinib HCl (Catalog# : 20663)Sotuletinib, also known as BLZ945, is a potent and selective CSF-1R kinase inhibitor.
• 2383086-06-2 | Sonrotoclax (BGB-11417) (Catalog# : 20650)Sonrotoclax is an antineoplastic.
• 2546091-70-5 | SOP1812 (QN-302) (Catalog# : 20639)QN-302 是一种 G4选择性转录抑制剂。
• 256414-75-2 | SEW2871 (Catalog# : 20604)SEW2871 is a S1P1 agonist (sphingosine-1-phosphate type 1 receptor agonist). SEW2871
• 2765525-82-2 | STX-721 (Catalog# : 20576)STX-721 is a next-generation, orally delivered therapy, designed with potential best-
• 2648257-56-9 | STC-15 (Catalog# : 20549)STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me
• 2921961-53-5 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol (Catalog# : 20522)
• 2170746-98-0 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-5'-[[(trifluoromethyl)sulfonyl]oxy]-, 1,1-dimethylethyl ester (Catalog# : 20412)